This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Novel ARHGAP23‐FER fusion in a metastatic spindle cell–predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib. Issue 22 (21st September 2021)
Record Type:
Journal Article
Title:
Novel ARHGAP23‐FER fusion in a metastatic spindle cell–predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib. Issue 22 (21st September 2021)
Main Title:
Novel ARHGAP23‐FER fusion in a metastatic spindle cell–predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib
Abstract : A metastatic spindle‐cell soft‐tissue neoplasm was found to carry a novel ARHGAP23‐FER fusion. The tumor showed a rapid and sustained metabolic response to tyrosine kinase inhibitor lorlatinib.